138 related articles for article (PubMed ID: 6942907)
1. Vindesine and prednisone for remission induction in children with acute lymphocytic leukemia.
Vats TS; Mehta P; Trueworthy RC; Smith SD; Klopovich P
Cancer; 1981 Jun; 47(12):2789-92. PubMed ID: 6942907
[TBL] [Abstract][Full Text] [Related]
2. Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.
Garay G; Milone J; Dibar E; Pavlovsky S; Kvicala R; Sackmann Muriel F; Montres Varela D; Eppinger-Helft M
Cancer Chemother Pharmacol; 1983; 10(3):224-6. PubMed ID: 6345018
[TBL] [Abstract][Full Text] [Related]
3. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
[TBL] [Abstract][Full Text] [Related]
4. A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study.
Vats T; Buchanan G; Mehta P; Ragab A; Hvizdale E; Nitschke R; Link M; Beardsley GP; Maybee D; Krischer J
Invest New Drugs; 1992 Aug; 10(3):231-4. PubMed ID: 1428733
[TBL] [Abstract][Full Text] [Related]
5. Vindesine: a phase II study in childhood malignancies-a report for cancer and leukemia group B.
Ettinger LJ; Brecher M; Coleman M; Smithson WA; Patterson R; Russell EC; Necheles T; Jones B; Ohnuma T
Med Pediatr Oncol; 1982; 10(1):35-43. PubMed ID: 7038420
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial.
Anderson J; Krivit W; Chilcote R; Pyesmany A; Chard R; Hammond D
Cancer Treat Rep; 1981; 65(11-12):1015-9. PubMed ID: 6945911
[TBL] [Abstract][Full Text] [Related]
7. Combination of vindesine and prednisone in malignant lymphoma and acute leukemia.
Raich PC; Walker BK; Rogers JS; Subramanian VP; Fontana JA; Knost JA; Denning B
Cancer Treat Rep; 1983 May; 67(5):485-7. PubMed ID: 6573959
[TBL] [Abstract][Full Text] [Related]
8. An initial report of a phase-III trial comparing vindesine and vincristine for acute lymphocytic leukemia of childhood.
Krivit W; Chilcote R; Pyesmany A; Anderson J; Hammond D
Cancer Chemother Pharmacol; 1979; 2(4):267-70. PubMed ID: 287570
[TBL] [Abstract][Full Text] [Related]
9. Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas.
Bayssas M; Gouveia J; Ribaud P; Musset M; de Vassal F; Pico JL; de Luca L; Misset JL; Machover D; Belpomme D; Schwarzenberg L; Jasmin C; Hayat M; Mathé G
Cancer Chemother Pharmacol; 1979; 2(4):247-55. PubMed ID: 287569
[TBL] [Abstract][Full Text] [Related]
10. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
Ueda T; Masaoka T; Shibata H; Kubota Y; Saigo K; Kusakabe H; Takubo T; Nakamura H; Yoshitake J; Ishigami S
Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
[TBL] [Abstract][Full Text] [Related]
11. Phase I evaluation of vindesine in children: a Southwest Oncology Group pilot study.
Komp D; Vats T; Shepherd DA; Vietti T; Hoogstraten B; Haas CD
Med Pediatr Oncol; 1980; 8(3):243-50. PubMed ID: 7193278
[TBL] [Abstract][Full Text] [Related]
12. [Phase II study of vindesine in hematological malignancies].
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
[TBL] [Abstract][Full Text] [Related]
13. [A randomized controlled study on vindesine and vincristine in combination with prednisolone in the treatment of adult acute lymphocytic leukemia and blastic crisis of chronic myeloid leukemia].
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2500-8. PubMed ID: 6580840
[TBL] [Abstract][Full Text] [Related]
14. [Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
Maraninchi D; Gastaut JA; Tubiana N; Carcassonne Y
Bull Cancer; 1981; 68(4):338-42. PubMed ID: 6947833
[TBL] [Abstract][Full Text] [Related]
15. VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia.
Rivera G; Bowman WP; Murphy SB; Dahl GV; Aur RJ; Kalwinsky DK; Wood A; Stagner S; Avery TL
Med Pediatr Oncol; 1982; 10(5):439-46. PubMed ID: 6958957
[TBL] [Abstract][Full Text] [Related]
16. A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma.
Yau JC; Yap YY; Buzdar AU; Hortobagyi GN; Bodey GP; Blumenschein GR
Cancer; 1985 Jan; 55(2):337-40. PubMed ID: 3880657
[TBL] [Abstract][Full Text] [Related]
17. Vindesine-prednisone in the treatment of blast crisis of chronic myeloid leukemia.
Lemoine F; Najman A; Laporte JP; Gorin NC; Duhamel G
Cancer Treat Rep; 1985 Feb; 69(2):203-4. PubMed ID: 3855698
[TBL] [Abstract][Full Text] [Related]
18. [A case of refractory acute lymphocytic leukemia who achieved a complete remission by mitoxantrone].
Yoshikawa H; Sao H; Tahara T; Akao Y; Yoshikawa S
Gan To Kagaku Ryoho; 1984 Mar; 11(3):515-20. PubMed ID: 6584088
[TBL] [Abstract][Full Text] [Related]
19. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia.
Chello PL; Sirotnak FM
Cancer Treat Rep; 1981; 65(11-12):1049-53. PubMed ID: 7296551
[TBL] [Abstract][Full Text] [Related]
20. [Vindesine plus L-asparaginase and prednisolone therapy (VDS-VLP therapy) for remission induction in children with relapsed acute lymphoblastic leukemia].
Hara T; Koike K; Tsukada M; Komiyama A; Akabane T
Rinsho Ketsueki; 1983 May; 24(5):540-6. PubMed ID: 6577209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
